Investment Insights

Biogen Receives Health Canada Authorization for ZURZUVAEâ„¢ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada

Biogen Receives Health Canada Authorization for ZURZUVAEâ„¢ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in

Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada Read Post »

Scroll to Top